Quantbot Technologies LP Axsome Therapeutics, Inc. Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$21.74 - $46.75 $91,786 - $197,378	4,222 Added 106.72%	8,178 $313,000
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $93,757 - $163,738	3,956 New	3,956 $163,000
Q1 2020 May 13, 2020	SELL	$41.2 - $101.31 $14,667 - $36,066	-356 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$16.71 - $106.24 $49,628 - $315,532	-2,970 Reduced 89.3%	356 $36,000
Q3 2019 Nov 12, 2019	BUY	$20.24 - $29.16 $15,584 - $22,453	770 Added 30.13%	3,326 $67,000
Q2 2019 Aug 13, 2019	BUY	$13.46 - $25.75 $34,403 - $65,817	2,556 New	2,556 $65,000

288

40.4M

365K

428K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.85B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.